Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (21)

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Economic impact of the first pass effect in mechanical thrombectomy for acute ischaemic stroke treatment in Spain: A cost-effectiveness analysis from the national health system perspective

    BMJ Open, Vol. 12, Núm. 9

  3. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  4. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2020

  1. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584

2019

  1. PATJ Low Frequency Variants Are Associated with Worse Ischemic Stroke Functional Outcome: A Genome-Wide Meta-Analysis

    Circulation Research, Vol. 124, Núm. 1, pp. 114-120

2017

  1. GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke

    Stroke, Vol. 48, Núm. 5, pp. 1147-1153

2016

  1. Combination of thrombolysis and statins in acute stroke is safe: Results of the STARS randomized trial (Stroke Treatment With Acute Reperfusion and Simvastatin)

    Stroke, Vol. 47, Núm. 11, pp. 2870-2873

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

  2. How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up

    Journal of Neurology, Vol. 261, Núm. 8, pp. 1614-1621

2013

  1. Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603

2012

  1. A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke

    Annals of Neurology, Vol. 72, Núm. 5, pp. 716-729

  2. IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke

    Stroke, Vol. 43, Núm. 10, pp. 2659-2665

  3. Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores

    Cerebrovascular Diseases, Vol. 33, Núm. 2, pp. 182-189

  4. Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients

    Stroke, Vol. 43, Núm. 5, pp. 1398-1400

2011

  1. In-hospital stroke: A multi-centre prospective registry

    European Journal of Neurology, Vol. 18, Núm. 1, pp. 170-176

  2. Infartos cerebrales intrahospitalarios: datos del registro multicéntrico de pacientes con infarto cerebral ingresados en Cardiología y Cirugía Cardiaca

    Medicina Clinica, Vol. 137, Núm. 11, pp. 479-483

  3. Plan de asistencia sanitaria al ICTUS II. 2010

    Neurologia, Vol. 26, Núm. 7, pp. 383-396

2010

  1. Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: A case-control, meta-analysis and functional study

    Cerebrovascular Diseases, Vol. 29, Núm. 6, pp. 528-537

  2. The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals

    European Journal of Neurology, Vol. 17, Núm. 11, pp. 1390-1392